第一单位：
Structural Genomics Consortium, University of Toronto, Toronto, Ontario M5G 1L7, Canada.;Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, Ontario M5G 0A3, Canada.;Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario M5S 1A8, Canada.
作者：
Alice Shi Ming,Li [1]
;
Serah,Kimani [2]
;
Brian,Wilson [3]
;
Mahmoud,Noureldin [4]
;
Héctor,González-Álvarez [4]
;
Ahmed,Mamai [3]
;
Laurent,Hoffer [3]
;
John P,Guilinger [5]
;
Ying,Zhang [5]
;
Moritz,von Rechenberg [6]
;
Jeremy S,Disch [6]
;
Christopher J,Mulhern [6]
;
Belinda L,Slakman [6]
;
John W,Cuozzo [6]
;
Aiping,Dong [7]
;
Gennady,Poda [8]
;
Mohammed,Mohammed [3]
;
Punit,Saraon [3]
;
Manish,Mittal [9]
;
Pratik,Modh [9]
;
Vaibhavi,Rathod [9]
;
Bhashant,Patel [9]
;
Suzanne,Ackloo [7]
;
Vijayaratnam,Santhakumar [7]
;
Magdalena M,Szewczyk [7]
;
Dalia,Barsyte-Lovejoy [10]
;
Cheryl H,Arrowsmith [11]
;
Richard,Marcellus [3]
;
Marie-Aude,Guié [5]
;
Anthony D,Keefe [5]
;
Peter J,Brown [7]
;
Levon,Halabelian [10]
;
Rima,Al-Awar [12]
;
Masoud,Vedadi [1]
作者单位：
Structural Genomics Consortium, University of Toronto, Toronto, Ontario M5G 1L7, Canada.;Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, Ontario M5G 0A3, Canada.;Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario M5S 1A8, Canada.
[1]
Structural Genomics Consortium, University of Toronto, Toronto, Ontario M5G 1L7, Canada.;Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 2C1, Canada.
[2]
Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, Ontario M5G 0A3, Canada.
[3]
Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, Ontario M5G 0A3, Canada.;Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario M5S 1A8, Canada.
[4]
X-Chem Inc., Waltham, Massachusetts 02453, United States.
[5]
Relay Therapeutics, Cambridge, Massachusetts 02139, United States.
[6]
Structural Genomics Consortium, University of Toronto, Toronto, Ontario M5G 1L7, Canada.
[7]
Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, Ontario M5G 0A3, Canada.;Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario M5S 3M2, Canada.
[8]
Piramal Discovery Solutions, Pharmaceutical Special Economic Zone, Ahmedabad, Gujarat 382213, India.
[9]
Structural Genomics Consortium, University of Toronto, Toronto, Ontario M5G 1L7, Canada.;Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario M5S 1A8, Canada.
[10]
Structural Genomics Consortium, University of Toronto, Toronto, Ontario M5G 1L7, Canada.;Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 2C1, Canada.;Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5G 1L7, Canada.
[11]
Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, Ontario M5G 0A3, Canada.;Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario M5S 1A8, Canada.;Department of Chemistry, University of Toronto, Toronto, Ontario M5S 3H6, Canada.
[12]
DOI
10.1021/acs.jmedchem.2c02132
PMID
36948210
发布时间
2024-05-18
换一批
